DIDANOSINE Side Effects

6848591-5 | Immune Reconstitution Syndrome, Lung Disorder, Retinal Detachment, Uveitis, Visual Acuity Reduced
on Jul 06, 2010 Female patient from TURKEY , 36 years of age, was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome, lung disorder, retinal detachment, uveitis, visual acuity reduced. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).

6816290-1 | Diplopia, Eyelid Ptosis, Lipodystrophy Acquired, Mitochondrial Toxicity, Progressive External Ophthalmoplegia
Patient was taking Didanosine (View Usage). Patient had the following side effects: diplopia, eyelid ptosis, lipodystrophy acquired, mitochondrial toxicity, progressive external ophthalmoplegia on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , 52 years of age, . Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), DELAVIRDINE (View Delavirdine Review and Delavirdine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ).

6758978-7 | Ascites, Hepatic Encephalopathy, Oesophageal Varices Haemorrhage, Portal Hypertension, Varices Oesophageal
Adverse event was reported on May 28, 2010 by a Male patient taking Didanosine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , 40 years of age, After Didanosine was administered, patient had the following side effects: ascites, hepatic encephalopathy, oesophageal varices haemorrhage, portal hypertension, varices oesophageal. During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6719456-4 | Ascites, Encephalopathy, Fluid Retention, Hepatic Cirrhosis, Hepatic Fibrosis, Hepatitis, Portal Hypertension, Portal Vein Thrombosis, Varices Oesophageal
on May 10, 2010 Female patient from UNITED STATES , 52 years of age, weighting 124.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, encephalopathy, fluid retention, hepatic cirrhosis, hepatic fibrosis, hepatitis (What is hepatitis?), portal hypertension, portal vein thrombosis, varices oesophageal. Didanosine dosage: Not Sure. Standard Dose Daily Po. Patient was hospitalized.


6709901-2 | Diplopia, Eyelid Ptosis, Lipodystrophy Acquired, Mitochondrial Toxicity, Progressive External Ophthalmoplegia
on Apr 22, 2010 Female patient from UNITED STATES , 52 years of age, was treated with Didanosine (View Usage). Patient had the following side effects: diplopia, eyelid ptosis, lipodystrophy acquired, mitochondrial toxicity, progressive external ophthalmoplegia. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ TABS (View Efavirenz Tabs Review and Efavirenz Tabs Label ), RALTEGRAVIR (Tab) (View Raltegravir Review and Raltegravir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ).

6698218-0 | Headache, Mitral Valve Incompetence, Orthostatic Hypotension, Syncope, Tricuspid Valve Incompetence
Patient was taking Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: headache (What is headache?), mitral valve incompetence, orthostatic hypotension, syncope, tricuspid valve incompetence on Apr 22, 2010 from UNITED STATES Additional patient health information: Female patient , 30 years of age, weighting 114.6 lb, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RALTEGRAVIR (1 Df = 1 Tabs) (View Raltegravir Review and Raltegravir Label ), KIVEXA (1df:1tabs) (View Kivexa Review and Kivexa Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6681610-8 | Syncope
Adverse event was reported on Apr 08, 2010 by a Female patient taking Didanosine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 30 years of age, weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: syncope. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RALTEGRAVIR (Tabs) (View Raltegravir Review and Raltegravir Label ), KIVEXA (1df:1tabs) (View Kivexa Review and Kivexa Label ). Patient was hospitalized.

6635755-9 | Lipodystrophy Acquired, Osteonecrosis, Pulmonary Tuberculosis
on Feb 22, 2010 Male patient from , 45 years of age, weighting 145.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient had the following side effects: lipodystrophy acquired, osteonecrosis (What is osteonecrosis?), pulmonary tuberculosis. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6635754-7 | Dyspepsia, Mobility Decreased, Osteonecrosis, Treatment Failure
on Feb 22, 2010 Male patient from , 33 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: dyspepsia, mobility decreased, osteonecrosis (What is osteonecrosis?), treatment failure. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ). Patient was hospitalized.

6635753-5 | Osteonecrosis, Treatment Failure, Virologic Failure
Patient was taking Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?), treatment failure, virologic failure on Feb 22, 2010 from Additional patient health information: Male patient , 44 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6620473-3 | Ascites, Portal Hypertension, Splenomegaly, Varices Oesophageal
Adverse event was reported on Mar 08, 2010 by a Female patient taking Didanosine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , child 5 years of age, Patient had the following side effects: ascites, portal hypertension, splenomegaly, varices oesophageal.

6609918-2 | Abdominal Distension, Abdominal Pain, Alcohol Abuse, Cholelithiasis, Chronic Hepatitis, Confusional State, Convulsion, Gastritis, Hepatic Cirrhosis
on Feb 09, 2010 Male patient from ITALY , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), alcohol abuse, cholelithiasis, chronic hepatitis, confusional state, convulsion, gastritis, hepatic cirrhosis. Didanosine dosage: 400mg, Daily. During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE (150/250mg, Bid) (View Lamivudine And Zidovudine Review and Lamivudine And Zidovudine Label ), STAVUDINE (40mg - Bid) (View Stavudine Review and Stavudine Label ), EFAVIRENZ (600mg - Daily) (View Efavirenz Review and Efavirenz Label ), TENOFOVIR (300mg - Daily ; 300mg - Daily) (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE (200 Mg - Daily) (View Emtricitabine Review and Emtricitabine Label ). Patient was hospitalized.

6587958-X | Gastritis, Hepatic Cirrhosis, Lactic Acidosis
on Feb 08, 2010 Male patient from ITALY , 43 years of age, was diagnosed with alcohol abuse and was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: gastritis, hepatic cirrhosis, lactic acidosis. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE + ZIDOVUDINE (1 Df=150/250) (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (1df-200/300 Mg) (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), FOSAMPRENAVIR CALCIUM (View Fosamprenavir Calcium Review and Fosamprenavir Calcium Label ). Patient was hospitalized.

6583705-6 | Coagulopathy, Encephalopathy, Jaundice, Pancreatitis
Patient was taking Didanosine (View Usage). Patient had the following side effects: coagulopathy, encephalopathy, jaundice (What is jaundice?), pancreatitis on Feb 13, 2010 from UNITED STATES Additional patient health information: Male patient , 24 years of age, weighting 156.5 lb, was diagnosed with acquired immunodeficiency syndrome and. Didanosine dosage: Oral 047. Patient was hospitalized.

6571259-X | Acute Hepatic Failure, Cachexia, Cholestasis, Graft Dysfunction, Hepatic Encephalopathy, Hepatic Necrosis, Hepatitis, Hyperlipidaemia, Hypertension
Adverse event was reported on Jan 16, 2010 by a Male patient taking Didanosine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Location: UNITED KINGDOM , child 9 years of age, After Didanosine was administered, patient had the following side effects: acute hepatic failure, cachexia, cholestasis, graft dysfunction, hepatic encephalopathy, hepatic necrosis, hepatitis (What is hepatitis?), hyperlipidaemia, hypertension. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), SULFAMETHOXAZOLE TRIMETHOPRIM (View Sulfamethoxazole Trimethoprim Review and Sulfamethoxazole Trimethoprim Label ), KIVEXA (LAMIVUDINE+ABACAVIR) (View Kivexa (lamivudine+abacavir) Review and Kivexa (lamivudine+abacavir) Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6532959-0 | Immune Reconstitution Syndrome, Progressive Multifocal Leukoencephalopathy
on Jan 04, 2010 Female patient from UNITED STATES , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome, progressive multifocal leukoencephalopathy. Didanosine dosage: . During the same period patient was treated with NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ).

6525666-1 | Immune Reconstitution Syndrome, Progressive Multifocal Leukoencephalopathy
on Dec 21, 2009 Female patient from UNITED STATES , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient had the following side effects: immune reconstitution syndrome, progressive multifocal leukoencephalopathy. Didanosine dosage: . During the same period patient was treated with NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ).

6517804-1 | Oesophageal Varices Haemorrhage, Portal Hypertension
Patient was taking Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: oesophageal varices haemorrhage, portal hypertension on Dec 03, 2009 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: . Patient was hospitalized.

6486558-X | Cutaneous Lupus Erythematosus
Adverse event was reported on Dec 07, 2009 by a Female patient taking Didanosine (View Usage) (Dosage: ) . Location: FRANCE , 35 years of age, Patient experienced the following unwanted or unexpected effects: cutaneous lupus erythematosus. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).

6478782-7 | Oesophageal Varices Haemorrhage, Portal Hypertension
on Dec 02, 2009 Male patient from UNITED STATES , 59 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Didanosine (View Usage). Patient had the following side effects: oesophageal varices haemorrhage, portal hypertension. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6461724-8 | Oesophageal Varices Haemorrhage, Portal Hypertension
on Nov 23, 2009 Male patient from UNITED STATES , 59 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: oesophageal varices haemorrhage, portal hypertension. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6408647-8 | Gait Disturbance, Parkinsonism, Rapid Eye Movements Sleep Abnormal
Patient was taking Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: gait disturbance, parkinsonism, rapid eye movements sleep abnormal on Oct 05, 2009 from AUSTRALIA Additional patient health information: Male patient , 53 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ).

6406630-X | Diplopia, Dysphagia, Eyelid Ptosis, Lipodystrophy Acquired, Mitochondrial Toxicity, Ophthalmoplegia
Adverse event was reported on Sep 23, 2009 by a Male patient taking Didanosine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 54 years of age, Patient had the following side effects: diplopia, dysphagia, eyelid ptosis, lipodystrophy acquired, mitochondrial toxicity, ophthalmoplegia. During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), TDF (View Tdf Review and Tdf Label ).

6387920-6 | Oesophageal Varices Haemorrhage, Portal Hypertension, Portal Hypertensive Gastropathy, Splenomegaly
on Sep 15, 2009 Male patient from , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: oesophageal varices haemorrhage, portal hypertension, portal hypertensive gastropathy, splenomegaly. Didanosine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6366250-2 | Biopsy Liver Abnormal, Portal Hypertension, Portal Hypertensive Gastropathy, Splenomegaly
on Aug 31, 2009 Male patient from , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy liver abnormal, portal hypertension, portal hypertensive gastropathy, splenomegaly. Didanosine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6359142-6 | Portal Hypertension, Pulmonary Hypertension
Patient was taking Didanosine (View Usage). Patient had the following side effects: portal hypertension, pulmonary hypertension (What is pulmonary hypertension?) on Sep 04, 2009 from SPAIN Additional patient health information: Female patient , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: Unk. During the same period patient was treated with SAQUINAVIR (Unk) (View Saquinavir Review and Saquinavir Label ), INDINIVIR SULFATE (Unk) (View Indinivir Sulfate Review and Indinivir Sulfate Label ), LOPINAVIR (Unk) (View Lopinavir Review and Lopinavir Label ), NEVIRAPINE (Unk) (View Nevirapine Review and Nevirapine Label ), STAVUDINE (Unk) (View Stavudine Review and Stavudine Label ), LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ), RITONAVIR (Unk) (View Ritonavir Review and Ritonavir Label ).

6359141-4 | Portal Hypertension
Adverse event was reported on Sep 04, 2009 by a Female patient taking Didanosine (View Usage) (Dosage: Unk) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , 36 years of age, After Didanosine was administered, patient had the following side effects: portal hypertension. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ).

6359140-2 | Portal Hypertension
on Sep 04, 2009 Female patient from SPAIN , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: portal hypertension. Didanosine dosage: Unk. During the same period patient was treated with EFAVIRENZ (Unk) (View Efavirenz Review and Efavirenz Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ).

6359123-2 | Portal Hypertension, Pulmonary Hypertension
on Sep 04, 2009 Male patient from SPAIN , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient had the following side effects: portal hypertension, pulmonary hypertension (What is pulmonary hypertension?). Didanosine dosage: Unk. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6359122-0 | Portal Hypertension, Pulmonary Hypertension
Patient was taking Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: portal hypertension, pulmonary hypertension (What is pulmonary hypertension?) on Sep 04, 2009 from SPAIN Additional patient health information: Female patient , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: Unk. During the same period patient was treated with NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6359119-0 | Portal Hypertension, Pulmonary Hypertension
Adverse event was reported on Sep 04, 2009 by a Male patient taking Didanosine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , 57 years of age, Patient experienced the following unwanted or unexpected effects: portal hypertension, pulmonary hypertension (What is pulmonary hypertension?). During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ).

6355228-0 | Portal Hypertension
on Sep 01, 2009 Male patient from SPAIN , 55 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient had the following side effects: portal hypertension. Didanosine dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6345499-9 | Portal Hypertension
on Aug 31, 2009 Female patient from SPAIN , 43 years of age, was treated with Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: portal hypertension. Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6345497-5 | Portal Hypertension
Patient was taking Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: portal hypertension on Aug 31, 2009 from SPAIN Additional patient health information: Female patient , 48 years of age, . Didanosine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6345496-3 | Portal Hypertension
Adverse event was reported on Aug 31, 2009 by a Male patient taking Didanosine (View Usage) (Dosage: ) . Location: SPAIN , 40 years of age, Patient had the following side effects: portal hypertension. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6345495-1 | Portal Hypertension
on Aug 31, 2009 Male patient from SPAIN , 48 years of age, was treated with Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: portal hypertension. Didanosine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ).

6345493-8 | Portal Hypertension
on Aug 31, 2009 Male patient from SPAIN , 55 years of age, was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: portal hypertension. Didanosine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), FOSAMPRENAVIR CALCIUM (View Fosamprenavir Calcium Review and Fosamprenavir Calcium Label ).

6345483-5 | Portal Hypertension
Patient was taking Didanosine (View Usage). Patient had the following side effects: portal hypertension on Aug 31, 2009 from SPAIN Additional patient health information: Male patient , 57 years of age, . Didanosine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6345481-1 | Portal Hypertension, Portal Hypertensive Gastropathy
Adverse event was reported on Aug 31, 2009 by a Female patient taking Didanosine (View Usage) (Dosage: ) . Location: SPAIN , 36 years of age, After Didanosine was administered, patient had the following side effects: portal hypertension, portal hypertensive gastropathy. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6344123-9 | Portal Hypertension
on Aug 31, 2009 Female patient from SPAIN , 46 years of age, was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: portal hypertension. Didanosine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6340457-2 | Portal Hypertension
on Aug 25, 2009 Female patient from SPAIN , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient had the following side effects: portal hypertension. Didanosine dosage: Unk. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ).

6340455-9 | Portal Hypertension
Patient was taking Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: portal hypertension on Aug 25, 2009 from SPAIN Additional patient health information: Female patient , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: Unk. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ).

6340450-X | Portal Hypertension, Pulmonary Hypertension
Adverse event was reported on Aug 25, 2009 by a Female patient taking Didanosine (View Usage) (Dosage: Unk) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , 43 years of age, Patient experienced the following unwanted or unexpected effects: portal hypertension, pulmonary hypertension (What is pulmonary hypertension?). During the same period patient was treated with SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6340449-3 | Portal Hypertension, Pulmonary Hypertension
on Aug 25, 2009 Male patient from SPAIN , 57 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient had the following side effects: portal hypertension, pulmonary hypertension (What is pulmonary hypertension?). Didanosine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ).

6340447-X | Portal Hypertension, Pulmonary Hypertension
on Aug 25, 2009 Female patient from SPAIN , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: portal hypertension, pulmonary hypertension (What is pulmonary hypertension?). Didanosine dosage: . During the same period patient was treated with NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6340446-8 | Portal Hypertension, Pulmonary Hypertension
Patient was taking Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: portal hypertension, pulmonary hypertension (What is pulmonary hypertension?) on Aug 25, 2009 from SPAIN Additional patient health information: Male patient , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6326603-5 | Ascites, Intestinal Obstruction, Peritoneal Fibrosis
Adverse event was reported on Aug 21, 2009 by a Male patient taking Didanosine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , 51 years of age, weighting 105.8 lb, Patient had the following side effects: ascites, intestinal obstruction, peritoneal fibrosis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized and became disabled.

6318492-X | Ascites, Hepatic Cirrhosis, Intestinal Obstruction, Peritoneal Fibrosis
on Aug 19, 2009 Male patient from UNITED KINGDOM , 51 years of age, weighting 105.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). After Didanosine was administered, patient had the following side effects: ascites, hepatic cirrhosis, intestinal obstruction, peritoneal fibrosis. Didanosine dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized and became disabled.

6295950-8 | Fanconi Syndrome, Nephrogenic Diabetes Insipidus
on Jul 20, 2009 Male patient from UNITED STATES , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Didanosine (View Usage). Patient experienced the following unwanted or unexpected effects: fanconi syndrome, nephrogenic diabetes insipidus. Didanosine dosage: 250mg - Daily. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), RITOVIR BOOSTER (View Ritovir-booster Review and Ritovir-booster Label ), FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ). Patient was hospitalized.

6295921-1 | Fanconi Syndrome, Hypophosphataemia, Hypouricaemia, Metabolic Acidosis, Nephrogenic Diabetes Insipidus, Renal Failure
Patient was taking Didanosine (View Usage). Patient had the following side effects: fanconi syndrome, hypophosphataemia, hypouricaemia, metabolic acidosis, nephrogenic diabetes insipidus, renal failure on Jul 20, 2009 from UNITED STATES Additional patient health information: Male patient , 32 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Didanosine dosage: 250mg - Daily. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), DAPSONE (View Dapsone Review and Dapsone Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.